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Abstract
Background: The role of pathogenic mycobacteria in diabetes has been a focus of speculation
since a decade without any meaningful insights into the mechanism of diabetes causation vis a vis
mycobacterial factors. Two of our studies based on PCR identification of mycobacterial DNA and
detection of antibodies specific to the recombinant antigens and whole cell lysates of the
Mycobacterium avium subsp. paratuberculosis (MAP) shown a clear association of MAP with the
presence of type 1 diabetes mellitus (T1DM).
Methods: In this study, we sought to investigate if or not type 2 diabetes (T2DM) patients harbour
humoral responses to MAP. Using three different MAP antigen preparations, humoral antibody
profiles were estimated for 57 T2DM patients and 57 healthy controls. Statistical analysis was
performed with the Chi-square test with Yates' corrections.
Results: We observed insignificant levels of humoral antibodies against recombinant heparin
binding haemagglutinin (HbHA), glycosyl transferase (Gsd) and MAP whole cell lysate in the blood
of subjects with T2DM as compared to healthy controls.
Conclusion: We found no obvious association of MAP with the incidence of T2DM in Sardinian
patients.
Background
Mycobacterium avium subspecies paratuberculosis (MAP) is
an important pathogen whose role in autoimmune dis-
eases such as Crohn's disease and diabetes has been
debated [1-4].
Type 2 diabetes mellitus (T2DM) has become an epi-
demic, and virtually no physician is without patients who
have the disease [5,6]. Adult-onset diabetes mellitus or
type 2 diabetes haunts more than 10% of the population
in western countries in the age of 30 years old or more [7]
and about 20% of people above 75 years of age [8,9].
Moreover, over the last decade, it has become apparent
that type 2 diabetes is extending not only to the young
adult population but also found in adolescents and even,
occasionally, in children [5]. The incidence is on the rise
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due to increased longevity and life expectancy and change
in lifestyles including dietary habits, diminishing physical
activity and rampancy of obesity, an increasing trend in
many countries [5,6].
Type 1 diabetes mellitus (T1DM) on the other hand is an
insulin deficiency syndrome wherein the role of an infec-
tious trigger such as MAP is becoming increasingly evident
[10,11]. In our recent studies based on MAP specific DNA
and antibody detection [10,11], we observed MAP to be
an important link in T1DM in Sardinian diabetic patients
who were free of tuberculosis and Crohn's disease.
Previous work [12] demonstrated low levels of antibodies
against the 65 kDa heat shock protein (Hsp65) in estab-
lished T1DM and T2DM cases. Heat shock proteins play
an important role in auto-immune diseases and infection
[1,8,9,12]. Human glutamic acid decarboxylase (Gad) the
prime antigen in Type 1 diabetes has similar amino
epitopes as that of Hsp65. Moreover, it is accepted that
low levels of Hsp65 antibodies in patients with estab-
lished diabetes is probably a manifestation of impaired
immunity induced by the diabetic state.
In the present study, we show that T2DM patients from
Sardinia, in contrast to those with T1DM, do not harbour
significant levels of anti Map antibodies in their blood.
This finding negates involvement of MAP in T2DM and
thereby reaffirms our hypothesis that T1DM (as against
T2DM) possibly results from MAP acting as an infectious
trigger.
Methods
A total of 114 participants comprising of 57 patients with
T2DM and 57 healthy controls were tested for the pres-
ence of MAP specific antibodies. Sera samples were
obtained from these subjects after confirming that they
were definitely negative for the presence of tuberculosis
(negative to PPD and not BCG vaccinated) and autoim-
mune and genetic diseases other than diabetes. Clinical
diagnosis for T2DM was confirmed in the Diabetology
Service of the Sassari University Clinics prior to the enrol-
ment of the test subjects. Blood samples were obtained
after written informed consents and after approval of the
ethics committee of the University of Sassari. Sera samples
were made into aliquots and stored at -20°C for short
term storage (<6 months) and -80°C for long term storage
(>6 months).
Target diagnostic antigens such as recombinant HbHA.
Gsd and the whole cell lysates of the MAP bacteria were
available from our previous studies [11,13].
Enzyme linked immunosorbent assay (ELISA) was per-
formed to detect humoral response [in test subjects
(T2DM) and controls] against the recombinant MAP anti-
gens and the whole cell lysates. Briefly, 5 μg/ml of crude
MAP lysate, HbHA and Gsd antigens in carbonate-bicar-
bonate buffer (14.2 mM Na2CO3, 34.9 mM NaHCO3, 3.1
mM NaN3, pH 9.5) were used individually to coat the
wells of flat-bottom 96-well immunoplates (Maxisorp;
Nunc, Roskilde, Denmark), overnight at 4°C. Next day,
plates were blocked for 1 h with 200 μl of 5% non-fat
dried milk (SIGMA) and following two washing steps
with phosphate buffered saline (PBS) containing 0.05%
Tween 20 (PBS-T), serum samples was added at 1:100
dilution. After 2 h of incubation, three washing steps with
PBS-T were performed to remove any unbound antibody.
A second incubation period followed, and 100 μl of opti-
mally diluted (1:1000) anti-human immunoglobulin G
(IgG)-alkaline phosphatase conjugated antibody (Sigma)
was added for 1 h at 37°C. Plates were washed four times
in PBS-T before 200 μl of p-nitrophenylphosphate
(SIGMA FAST™ pNPP tablets Sigma-Aldrich) substrate for
alkaline phosphatase (AP) enzyme was added to each
well. Plates were incubated at 37°C in the dark until color
developed and were read at 405 nm by using a VERSATun-
able Max microplate reader (Molecular Devices, USA). As
a positive control, a T1DM patient's serum sample (No.
14) [11], which was previously found positive for MAP
PCR and in ELISA assays for all the three antigens tested
(HbHA, Gsd and MAP lysate) was included in each plate.
Since Gsd was fused with the affinity tag Maltose binding
protein (MBP), sera were tested with the LacZ-MBP con-
trol to evaluate a possible seroreactivity. Statistical analy-
sis was performed by the Chi-square test with Yates'
correction,  P  values were calculated using the online
Graph Pad scientific calculator, http://www.graph
pad.com quickcalcs_ttest1.cfm)
Results and Discussion
ELISA values were interpreted in the form of optical den-
sity (OD) and the values were plotted as shown (Figure 1).
An arbitrary cut-off was established as in the previous
work [11]. HbHA antigen ELISA titres with a cut-off titre
value 0.5 (Chi square equal to 0.000, P value equal to
0.9899); the Gsd protein cut-off value of 0.4 (Chi square
equal to 0.154 with 1 degrees of freedom, P value equal to
0.6945); MAP lysate cut-off value of 0.5 (Chi square equal
to 0.091 with 1 degrees of freedom, P value equal to
0.7627).
Results of the MAP antigen and whole cell ELISA have
been summarized in Figure 1. Overall, the ELISA values
were not significant to unravel any relationship between
MAP humoral response and the T2DM disease phenotype.
This is in contrast to the observations made with T1DM
cases where highly significant humoral immune
responses to all the three antigens have been documented
in the blood of subjects [11]. Also, T1DM patients wereAnnals of Clinical Microbiology and Antimicrobials 2008, 7:9 http://www.ann-clinmicrob.com/content/7/1/9
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Evaluation of serum samples from diabetic type II patients (left column) and healthy donors (right column) against HbHA  recombinant protein (A), Gsd recombinant protein (B) and MAP lysate (C) Figure 1
Evaluation of serum samples from diabetic type II patients (left column) and healthy donors (right column) against HbHA 
recombinant protein (A), Gsd recombinant protein (B) and MAP lysate (C). Data are presented as values of OD405 observed 
following ELISA, as described in the text. Data from a representative experiment out of three are shown. The median value for 
each group is indicated by a dark solid horizontal line.
A
B
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shown to harbour circulating loads of bacilli in their
peripheral blood as revealed by IS900 based PCR assays
[10]. The outcome of the IS900 based PCR assay in our
T2DM subjects were also insignificant as seen in case of
ELISA. This negates the possibility of a MAP bacteremia in
T2DM patients.
MAP is a multi-host pathogen with a broadest host range
comprising of many birds, animals and primates [14]. It
persists within the human gut in a Ziehl-Neelsen negative
"cell wall deficient form" [1,13] which could be the
potential source of antigens in the host that may direct
auto-immune responses. Deficiency of vitamin D has
been implicated as a risk factor for T1DM [8] and T2DM
(where vitamin D and calcium insufficiency may nega-
tively influence glycemia), whereas combined supple-
mentation with both the micronutrients may be
beneficial in optimizing glucose metabolism [3].
Recently, Vitamin D has been reported to be involved in
upregulation of an antimicrobial peptide thus limiting the
mycobacterial infections [15]. Such studies possibly help
linking the two diseases, diabetes and Crohn's, where
MAP could be the common agent putatively behaving as
environmental trigger of auto-immunity.
T2DM was linked to mycobacteria as early as in 1943 by
Hass and Huntington [16] and afterwards in 1964 [2] and
by Schwartz in 1972 [17]. Since then there is a massive
body of data that posed speculations on a possible myco-
bacterial involvement in diabetes [1,8-12,15]. Our results
here unequivocally refute such speculations through a
robust assay that used three different antigen preparations
which were previously shown to be having acceptable sen-
sitivity and specificity in case of T1DM.
Conclusion
In conclusion, we demonstrate that T2DM patients do not
have significant levels of anti MAP antibodies in contrast
to their T1DM counterparts. This seemingly hints at the
possibility where the involvement of immune dysregula-
tion caused by a persistent pathogen such as MAP (as
hypothesized in case of Crohn's disease and T1DM) in
T2DM becomes irrelevant as a possible mechanism. At the
same time, our observations put at rest the long driven
speculation on the involvement of a MAP infection as a
trigger in type 2 diabetes.
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